Healthcare provider profile · identity verified

Daniel J Stein, MD

Internal Medicine · EXCELSIOR, MN · NPI 1669449674

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	297	32
Pantoprazole Sodium	Pantoprazole Sodium	287	46
Levothyroxine Sodium	Levothyroxine Sodium	273	37
Gabapentin	Gabapentin	249	30
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	243	242
Metoprolol Succinate	Metoprolol Succinate	221	36
Furosemide	Furosemide	213	41
Omeprazole	Omeprazole	213	34
Amlodipine Besylate	Amlodipine Besylate	202	36
Atorvastatin Calcium	Atorvastatin Calcium	198	35
Shingrix	Varicella-Zoster Ge/As01b/Pf	191	191
Tamsulosin Hcl	Tamsulosin Hcl	184	22
Trazodone Hcl	Trazodone Hcl	156	28
Potassium Chloride	Potassium Chloride	139	26
Simvastatin	Simvastatin	133	12
Mirtazapine	Mirtazapine	126	19
Sertraline Hcl	Sertraline Hcl	119	21
Lisinopril	Lisinopril	110	19
Losartan Potassium	Losartan Potassium	110	18
Rosuvastatin Calcium	Rosuvastatin Calcium	106	12
Carvedilol	Carvedilol	101	16
Levetiracetam	Levetiracetam	101	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	97	29
Latanoprost	Latanoprost	95	19
Xarelto	Rivaroxaban	85	suppressed
Torsemide	Torsemide	83	11
Fluoxetine Hcl	Fluoxetine Hcl	79	suppressed
Duloxetine Hcl	Duloxetine Hcl	75	15
Buspirone Hcl	Buspirone Hcl	74	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	72	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	72	16
Escitalopram Oxalate	Escitalopram Oxalate	71	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	13
Amiodarone Hcl	Amiodarone Hcl	65	suppressed
Metformin Hcl	Metformin Hcl	63	suppressed
Donepezil Hcl	Donepezil Hcl	60	13
Ezetimibe	Ezetimibe	56	suppressed
Citalopram Hbr	Citalopram Hydrobromide	55	11
Primidone	Primidone	53	suppressed
Carbamazepine Er	Carbamazepine	52	suppressed
Hydralazine Hcl	Hydralazine Hcl	42	suppressed
Jardiance	Empagliflozin	42	suppressed
Prednisone	Prednisone	41	11
Baclofen	Baclofen	40	suppressed
Bupropion Xl	Bupropion Hcl	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Allopurinol	Allopurinol	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Divalproex Sodium	Divalproex Sodium	35	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	35	12
Montelukast Sodium	Montelukast Sodium	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Metformin Hcl Er	Metformin Hcl	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	13
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Creon	Lipase/Protease/Amylase	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Dilantin	Phenytoin Sodium Extended	26	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Famotidine	Famotidine	25	suppressed
Hydrocortisone	Hydrocortisone	25	suppressed
Sucralfate	Sucralfate	24	suppressed
Sulfasalazine Dr	Sulfasalazine	24	suppressed
Insulin Aspart Flexpen	Insulin Aspart	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	15
Timolol Maleate	Timolol Maleate	23	suppressed
Dutasteride	Dutasteride	22	suppressed
Moxifloxacin	Moxifloxacin Hcl	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	11
Budesonide Ec	Budesonide	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Nystatin	Nystatin	21	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Bumetanide	Bumetanide	19	suppressed
Carbamazepine	Carbamazepine	19	suppressed
Digoxin	Digoxin	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Cephalexin	Cephalexin	16	12
Aripiprazole	Aripiprazole	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Atenolol	Atenolol	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Olanzapine Odt	Olanzapine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Asmanex	Mometasone Furoate	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Methocarbamol	Methocarbamol	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Fluorometholone	Fluorometholone	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Ondansetron Odt	Ondansetron	12	12
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Cevimeline Hcl	Cevimeline Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error